Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2018 08:06 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing

The Federal Employee Health Benefit BCBS Program Adds Approximately 5.3 Million Covered Lives PARSIPPANY, NJ, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
November 07, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing

The Federal Employee Health Benefit BCBS Program Adds Approximately 5.3 Million Covered Lives PARSIPPANY, NJ, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
November 06, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results on Tuesday, November 13, 2018

PARSIPPANY, NJ, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it will report its third quarter 2018 financial results after the close of...
October 24, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Participation at the DJCON18

Including Participation in the Panel on the Impact of AI and Bioinformatics in Healthcare PARSIPPANY, NJ, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
October 22, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present at the 36th Annual Lab Institute 2018

Discussing Methods for Securing Coverage and Reimbursement for New Technologies PARSIPPANY, NJ, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today...
October 15, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Presents Favorable New Data at the 88th Annual Meeting of the American Thyroid Association (ATA)

ThyGenX® and ThyraMIR® Data from Clinical Experience Study Shows Positive Results PARSIPPANY, NJ, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced that...
October 10, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics CEO Provides Corporate Update

PARSIPPANY, NJ, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) is pleased to provide a corporate update to shareholders on current business activities from its Chief...
October 04, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Enters into Agreement with Renowned Integrated Health System

Agreement with Piedmont Healthcare Covers Company’s Pancreatic Cancer Test PARSIPPANY, NJ, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ: IDXG) reported today that it has...
October 01, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present New Data at the 88th Annual Meeting of the American Thyroid Association (ATA) on October 5th

ThyGenX® and ThyraMIR® Data from Clinical Experience Study to be Featured at ATA Product Expo PARSIPPANY, NJ, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
September 24, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Reimbursement Expansion of ThyGeNEXT™

State of Pennsylvania and New York Approve Commercialization of New Thyroid Cancer Test PARSIPPANY, NJ, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG), announced...